Showing 741-750 of 1564 results for "".
- Diagnostic Challenges in Primary Pulmonary Adenocarcinoma with Signet-Ring Cell Featureshttps://reachmd.com/news/diagnostic-challenges-in-primary-pulmonary-adenocarcinoma-with-signet-ring-cell-features/2474588/Primary pulmonary adenocarcinoma with signet-ring cell features (PASRF) remains one of the more elusive and diagnostically complex subtypes of lung cancer. Its morphological resemblance to metastatic signet-ring cell carcinomas (SRCCs) originating from the gastroin
- Cancer Immunotherapy: Enhancing TIL Therapy Through B Cell Activationhttps://reachmd.com/news/cancer-immunotherapy-enhancing-til-therapy-through-b-cell-activation/2474106/The dynamic field of oncology sees constant evolution in immunotherapy advancing treatment standards. A notable development is the strategic use of B cell activation to increase TIL therapy success. By leveraging B cells’ complementary role, this strategy may refin
- Unraveling Metabolic Mysteries: Blood-Derived Immune Cells and Dravet Syndromehttps://reachmd.com/news/unraveling-metabolic-mysteries-blood-derived-immune-cells-and-dravet-syndrome/2471800/Recent research from the University of Colorado Anschutz Medical Campus uncovers significant metabolic impairments in lymphoblast cell lines from children with Dravet syndrome, underscoring a vital connection between immune cell energy management and neurological function.<
- Harnessing Genetically Modified Natural Killer Cells to Revolutionize Cancer Immunotherapyhttps://reachmd.com/news/harnessing-genetically-modified-natural-killer-cells-to-revolutionize-cancer-immunotherapy/2471799/Recent advancements in oncology, genetics, and health technology are forging new paths in cancer therapy. Researchers are now transforming NK cells—vital components of the immune system—using CRISPR/Cas9 technology. These innovations empower cells to better identif
- New Insights on How Melanoma Cells Resist Cancer Immunotherapyhttps://reachmd.com/news/new-insights-on-how-melanoma-cells-resist-cancer-immunotherapy/2468039/How would you summarize your study for a lay audience? Immune checkpoint inhibitors are cancer fighting drugs that help the immune system do its job of detecting and attacking tumor cells. Programmed Cell Death 1 (PD-1)
- Weight-Loss Drugs Could Exploit Fat Cells’ White-to-Beige' Mechanismhttps://reachmd.com/news/weight-loss-drugs-could-exploit-fat-cells-white-to-beige-mechanism/2467371/Researchers at UC San Francisco have figured out how to turn ordinary white fat cells, which store calories, into beige fat cells that burn calories to maintain body temperature. Until now researchers have largely believed that creating beige fat might require starting f
- Scientists Discover How to Make Ordinary Fat Cells Burn Calorieshttps://reachmd.com/news/scientists-discover-how-to-make-ordinary-fat-cells-burn-calories/2467387/Researchers at UC San Francisco have figured out how to turn ordinary white fat cells, which store calories, into beige fat cells that burn calories to maintain body temperature. The discovery in mice could open the door to developing a new class of weight-loss drugs and may exp
- Research Uncovers How to Target ‘Sleeping’ Breast Cancer Cells and Prevent Relapsehttps://reachmd.com/news/research-uncovers-how-to-target-sleeping-breast-cancer-cells-and-prevent-relapse/2462497/Image: Breast cancer cells. Credit: Anne Weston. Scientists have discovered how breast cancer cells can ‘hibernate’ to avoid treatment and ‘wake up’ years later – causing a relapse that is more difficult to treat. Their early stage research,
- The Role of T–B Cell Cooperation in CNS Autoimmunityhttps://reachmd.com/news/the-role-of-tb-cell-cooperation-in-cns-autoimmunity/2474338/Recent discoveries are shedding new light on the critical role that T–B cell cooperation plays within ectopic lymphoid follicles in driving central nervous system (CNS) autoimmunity. Understanding how these cellular interactions fuel autoimmune propagation is openi
- Exploring Naïve B Cell Responses to Prepandemic Influenzahttps://reachmd.com/news/exploring-naive-b-cell-responses-to-prepandemic-influenza/2471027/Quick Summary Human naïve B cells have shown the ability to target and engage with hemagglutinin of highly pathogenic avian influenza viruses, including H5Nx strains. This discovery, detailed by Feldman et al. in Science Immunology, underscores the potentia